The researchers, working with cell cultures, first observed how individual tumour
cells kill specific cells in the vascular wall, called endothelial cells.
Scientists from the Max Planck Institute for Heart and Lung Research in Bad Nauheim and Goethe University Frankfurt have now shown that tumour
cells kill specific cells in the vascular wall.
Not exact matches
If I believed it were all ending on a
specific day you could bet your bottom dollar I wouldn't waste my remaining life warning everyone... I'd be
killing every last brain
cell available to me and enjoying this incredible planet!
«Once this novel tumor - homing agent binds to the EphA2 receptor, the oncogene functions as a cancer -
specific molecular Trojan horse for paclitaxel, carrying the drug inside the cancel
cell,
killing the
cell, and thwarting metastasis,» said Maurizio Pellecchia, a professor of biomedical sciences at UCR's School of Medicine who led the research.
The findings inject hard facts into a debate that has long divided the medical community, with many radiation oncologists preferring adjuvant therapy — radiation given soon after prostate removal to
kill off any remaining cancer
cells — and many urologists preferring salvage therapy — radiation given later, when prostate -
specific antigen tests suggest it's needed.
While the individual effects of the drugs on virus -
specific CTL differ somewhat depending on
specific assays, schedules, and doses, treatment with any of the three HDAC inhibitors impaired the ability of CTL to
kill HIV - infected immune
cells.
By cutting gelsolin down to a
specific fragment and putting it into chemo - resistant cancer
cells, the international team discovered they could make these
cells susceptible to the cancer -
killing effects of cisplatin.
An APC - mimetic scaffold that was engineered to activate a
specific type of CAR - T
cell was able to generate higher numbers of the modified T
cells over longer periods of culture than analogously designed expansion beads, and the resulting
cells were similarly effective in
killing the lymphoma
cells in the mice.
Some
cell types were not
killed by treatment with PAL, suggesting it could be used as a
specific tumor therapy.
Over the past two years, investigators from the Perelman School of Medicine at the University of Pennsylvania have reported results from a human trial in GBM using chimeric antigen receptor (CAR) T
cell therapy, through which patients» own T
cells were engineered to track down and
kill cancer
cells that express a tumor -
specific protein known as EGFRvIII.
The study, published by the journal Proceedings of the National Academy of Sciences, demonstrates that the Disney lab's compound, known as Targaprimir - 96, triggers breast cancer
cells to
kill themselves via programmed
cell death by precisely targeting a
specific RNA that ignites the cancer.
They work by sticking to
specific proteins found on the surface of cancer
cells, flagging them up to be
killed by the immune system.
The engineered T
cells also performed successfully in a mouse model of PV,
killing desmoglein -
specific B
cells and preventing blistering and other manifestations of autoimmunity in the animals.
«We were able to show that the treatment
killed all the Dsg3 -
specific B
cells, a proof of concept that this approach works,» Payne said.
To do this, they used T
cells that can recognize and
kill specific pathogens.
In a paper appearing in the journal ChemBioChem, Pentelute and colleagues showed that they could use this disarmed version of the anthrax toxin to deliver two proteins known as antibody mimics, which can
kill cancer
cells by disrupting
specific proteins inside the
cells.
Researchers from immune biology professor Annette Oxenius's group have now discovered what keeps NK
cells from
killing off their «colleagues from the other department» of the immune system: healthy CD8 +
cells are able to detect the immune messenger substance type 1 interferon, which binds to
specific receptors on the surface of these immune
cells and thereby conceals their stress.
She identified that
specific killing of myeloid
cells represents an additional mechanism of suppression mediated by Tr1
cells, and she contributed to the definition of a new protocol for Tr1
cell induction using IL - 10 gene transfer and in the discovery of the biomarkers of Tr1
cells.
So instead of taking a shotgun approach to
killing a cancer
cell, we are using a targeted approach that is not necessarily
specific to an anatomical site, but rather the
specific mutation identified in the tumor.
ATG
kills the
specific cells that are attacking the bone marrow stem
cells.
HIV attacks and
kills a
specific type of white blood
cell, called a CD4
cell.
The
specific antigen approach uses selected antigens that are also present in the patient's tumor so that the immune system will be educated to recognize the tumor antigen and
kill tumor
cells expressing the antigen.
Drug from Mediterranean Weed
Kills Tumor
Cells Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel — undetected by normal cells — through the bloodstream until activated by specific cancer prot
Cells Scientists at the Johns Hopkins Kimmel Cancer Center, working with Danish researchers, have developed a novel anticancer drug designed to travel — undetected by normal
cells — through the bloodstream until activated by specific cancer prot
cells — through the bloodstream until activated by
specific cancer proteins.
Their specialised
killing abilities depend upon their
cell surface receptor (T
cell receptor, TCR) that recognises
specific antigens expressed on their targets»
cell surface.
Natural killer (NK)
cells, the «rapid response»
cells of the innate immune system, can
kill virally infected
cells and thereby slow down an infection until antigen -
specific and clonally - expanded cytotoxic T
cells can be recruited to finish the job.
Similar to CTLs, these CD4 T
cells will be
specific to a tumor antigen, but unlike CTLs, they generally can not
kill antigen - bearing tumor
cells.
This process activates the CD8 T
cell and causes it to divide, creating millions of CTLs to
kill tumor
cells that bear that
specific tumor antigen, including neoantigens.
We believe DCs are the most important immune
cells to target because they initiate the
specific immune response that generates CTLs to
kill the tumor.
Thanks to I - chlor's photosensitizing property, laser light of
specific wavelengths applied to a tumor containing it causes cancer
cells to overheat,
killing them without affecting normal
cells.
A
specific chemical molecule helps to break down MYCN, which either
kills the cancer
cell or makes it mature into a harmless neuron.
HIV attacks and
kills a
specific type of white blood
cell, called a CD4
cell.
In fact, there are
specific plant compounds that actually
kill cancer
cells without harming the healthy
cells of the body.
They do not
kill cancerous or viral
cells, but regulate the action of
specific genes that control the production of cellular proteins that affect
cell growth.
RemedyLink Ellagic Acid contains a blend of USP grade ellagic acid and
specific herbs which offer many health benefits, some of which include inhibiting fungi and yeast growth,
killing bacteria, promoting the apoptosis of certain
cells, and more.
The immune system is made up of a team of different types of
cells that, while each having their own
specific function, work together to protect the body from foreign invaders: B -
cells produce antibodies; T -
cells conduct surveillance for potentially dangerous molecules and
kills dangerous
cells such as disease - causing bacteria; and macrophages are the scavenger
cells of your body acting like garbage trucks, cleaning up residue and removing potentially dangerous substances.
HOW VACCINES WORK After vaccination, the immune system is «trained» to recognize infectious agents by producing proteins called antibodies or activating
specific cells to
kill the agents.
In any of these forms, drugs are administered to
kill remaining cancer
cells after removing a tumor in surgery (adjuvant), shrink an existing tumor prior to surgery (neoadjuvant), or quicken remission for
specific blood - borne cancers (induction).